Sliding friction material
    1.
    发明授权
    Sliding friction material 失效
    滑动摩擦材料

    公开(公告)号:US08757342B2

    公开(公告)日:2014-06-24

    申请号:US13266196

    申请日:2010-03-11

    摘要: For reduction in size and weight, friction materials aiming at a high coefficient of kinetic friction have been developed. However, friction materials with a high coefficient of kinetic friction may cause sticking to a sliding partner material and deteriorated feeling in operation in particular in the initial running-in period during the initial stage of use. Therefore, the use of friction materials with a high coefficient of kinetic friction has been restricted. Since such sticking to the sliding partner material is less likely to occur after experiencing an initial running-in period, developed was a friction material in a form that is effective in prevention of sticking during the initial running-in period. Among sliding surfaces 5 between the friction material 3 and the sliding partner material 7, only the initial sliding surface 5′, or only the initial sliding surface 5′ and the vicinity thereof are in contact during the initial running-in period, and the area in contact with the sliding partner material gradually increases over time to full-area contact, that is, full contact of the whole sliding surfaces 5. The above constitution provides a sliding friction material having excellent sticking resistance with excellent friction performance and abrasion resistance.

    摘要翻译: 为了减小尺寸和重量,已经开发了针对高摩擦系数的摩擦材料。 然而,具有高动摩擦系数的摩擦材料可能会在使用初始阶段,特别是在初始进入期间,可能导致滑动伴侣材料的粘附和操作的恶化。 因此,使用具有高动摩擦系数的摩擦材料受到限制。 由于在经历初始磨合期之后不易发生滑动配合材料的粘附,所以显影为在初始运行期间有效防止粘着的形式的摩擦材料。 在摩擦材料3和滑动伴侣材料7之间的滑动表面5中,初始滑动面5'或初始滑动面5'及其附近仅在初始运行期间接触, 与滑动伴侣材料接触随着时间逐渐增加到全面接触,即整个滑动面5的完全接触。上述结构提供了具有优异的耐粘附性和优异的摩擦性能和耐磨性的滑动摩擦材料。

    Therapeutic agent for glomerular disease
    2.
    发明授权
    Therapeutic agent for glomerular disease 有权
    肾小球疾病治疗剂

    公开(公告)号:US07504415B2

    公开(公告)日:2009-03-17

    申请号:US10474194

    申请日:2002-04-18

    IPC分类号: A61K31/47

    CPC分类号: C07D215/14 A61K31/47

    摘要: The present invention is directed to a preventive or therapeutic agent for a glomerular disease comprising as an active ingredient a compound represented by formula (1): or a salt thereof. The preventive or therapeutic agent for glomerular diseases is useful for preventing or treating a variety of glomerular diseases including chronic glomerular nephritis.

    摘要翻译: 本发明涉及用于肾小球疾病的预防或治疗剂,其包含由式(1)表示的化合物或其盐作为活性成分。 肾小球疾病的预防或治疗剂可用于预防或治疗各种肾小球疾病,包括慢性肾小球性肾炎。

    Bis(2-aryl-5-pyridyl) derivatives
    9.
    发明授权
    Bis(2-aryl-5-pyridyl) derivatives 失效
    双(2-芳基-5-吡啶基)衍生物

    公开(公告)号:US06890940B2

    公开(公告)日:2005-05-10

    申请号:US09893680

    申请日:2001-06-29

    摘要: A bis(2-aryl-5-pyridyl) compound having formula (1) or a salt thereof: wherein A is a substituted or unsubstituted aromatic hydrocarbon group, and X is a substituent having one of the following formulas (2) to (4): wherein, in formula (2), R1 is a hydrogen atom or a di(lower alkyl)amino(lower alkyl) group, and m is an integer of 1 or 2; in formula (3), Y1 and Y2 each is a nitrogen atom or a CH group, and n is 0 or an integer of 1 to 6; in formula (4), R2 and R3 each is a hydrogen atom or a lower alkyl group, Z represents a single bond, a substituted methylene group, a substituted imino group, an oxygen atom or a cycloalkylene group, and p and q each is 0 or an integer of 1 to 6.

    摘要翻译: 具有式(1)的双(2-芳基-5-吡啶基)化合物或其盐:其中A是取代或未取代的芳族烃基,X是具有下式(2)至(4)中的一个的取代基 )其中,在式(2)中,R 1是氢原子或二(低级烷基)氨基(低级烷基)基团,m是1或2的整数; 在式(3)中,Y 1和Y 2各自为氮原子或CH基团,n为0或1至6的整数; 在式(4)中,R 2和R 3各自为氢原子或低级烷基,Z表示单键,取代亚甲基,取代亚氨基 基团,氧原子或亚环烷基,p和q各自为0或1〜6的整数。